Clinical Trial Update: Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to evaluate whether early administration of a PCSK9 inhibitor after acute myocardial infarction affects ventricular remod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Shanghai Tong Ren Hospital | Conditions: Early PCSK9 Inhibitor on Ventricular Remodling | Phase 4 | Status: RECRUITING